关于 "Cancer stem cell" 的结果41+ 个结果
- OT-82CAS: 1800487-55-1
OT-82 is a novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with average IC50s of 13.03 ??nM in non-HP cancer cells and 2.89? ?nM in HP cancer cells, respectively.
- Glaucocalyxin ACAS: 79498-31-0
Glaucocalyxin A is a biologically active ent-kauranoid diterpenoid isolated from Rabdosia japonica var. glaucocalyx with antitumor and anti-inflammatory activity. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
- PI-273CAS: 925069-34-7
PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
- TributyrinCAS: 60-01-5
Glycerol tributyrate (Tributyrin) is a triglyceride that may inhibit cell growth and induce cell differentiation.
Apoptosis - Rotundic acidCAS: 20137-37-5
Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.RA induces cell cycle arrest, DNA damage, and apoptosis by modulating the AKT/mTOR and MAPK pathways.
- RA-9CAS: 919091-63-7
RA-9 is a cell-permeable, potent and selective inhibitor of proteasome-associated deubiquitinating enzymes (DUBs) with favorable toxicity profile and anticancer activity. RA-9 selectively induces apoptosis in ovarian cancer cell lines.
- PicrocrocinCAS: 138-55-6
Picrocrocin, the chemical most responsible for the bitter taste of saffron, is isolated from saffron and inhibits proliferation of cancer cells.
Apoptosis - SintilimabCAS: 2072873-06-2
Sintilimab (anti-PD-1, IBI 308) is a fully human IgG4 monoclonal antibody that binds to PD-1 on the surface of T-cells, blocks the PD-1/PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells.
- Nivolumab (BMS-936558)CAS: 946414-94-4
Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。
- LinderalactoneCAS: 728-61-0
Linderalactone inhibits human lung cancer growth by modulating the expression of apoptosis-related proteins (Bax and Bcl-2) with an IC50 of 15 ?M in A-549 cells. Linderalactone induces G2/M cell cycle arrest and could also suppress the JAK/STAT signalling pathway. Linderalactone can be isolated from Radix linderae.
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC14882 | Salinomycin | 53003-10-4 | Other Apoptosis | ||
A selective cancer stem cell inhibitor | |||||
| GC91154 | 33-BCRP Inhibitor | - | Apoptosis | ||
一种BCRP抑制剂 | |||||
| GC14731 | MTT | 298-93-1 | Apoptosis | ||
A cell-permeable and positively charged tetrazolium dye | |||||
| GC10171 | Puromycin aminonucleoside | 58-60-6 | Aminopeptidase | ||
A glomerular epithelial cell toxin | |||||
| GC41261 | Flavokawain B | 1775-97-9 | Other Apoptosis | ||
Induces cancer cell apoptosis | |||||
| GC50282 | EC 19 | 1010694-08-2 | Other Apoptosis | ||
Synthetic retinoid; induces differentiation of stem cells | |||||
| GC12861 | Z-VAD-FMK | 187389-52-2 | Caspase | ||
Z-VAD-FMK(苄氧羰基-Val-Ala-Asp(OMe)氟甲基酮),是一种类似ICE的蛋白酶抑制剂,通过阻止CPP32转化为其活性形式来抑制细胞凋亡。 | |||||
| GC60278 | OT-82 | 1800487-55-1 | Metabolism | ||
OT-82 is a novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with average IC50s of 13.03 ??nM in non-HP cancer cells and 2.89? ?nM in HP cancer cells, respectively. | |||||
| GC12961 | Apicidin | 183506-66-3 | Histone Demethylases | ||
A cell-permeable HDAC inhibitor | |||||
| GC38606 | Glaucocalyxin A | 79498-31-0 | Other Apoptosis | ||
Glaucocalyxin A is a biologically active ent-kauranoid diterpenoid isolated from Rabdosia japonica var. glaucocalyx with antitumor and anti-inflammatory activity. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells. | |||||
| GC62676 | TJ191 | 1522415-97-9 | Apoptosis | ||
TJ191 is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells. | |||||
| GC39155 | PI-273 | 925069-34-7 | Other Apoptosis | ||
PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis. | |||||
| GC11908 | Cisplatin | 15663-27-1 | Ferroptosis | ||
顺铂是最好的、最早的基于金属的化疗药物之一,用于治疗广泛的实体癌症,如睾丸癌、卵巢癌、膀胱癌、肺癌、宫颈癌、头颈部肿瘤和胃癌等。 | |||||
| GC61349 | Tributyrin | 60-01-5 | Apoptosis | ||
Glycerol tributyrate (Tributyrin) is a triglyceride that may inhibit cell growth and induce cell differentiation. | |||||
| GC38609 | Rotundic acid | 20137-37-5 | Other Apoptosis | ||
Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.RA induces cell cycle arrest, DNA damage, and apoptosis by modulating the AKT/mTOR and MAPK pathways. | |||||
| GC43105 | C8 Ceramide (d18:1.8:0) | 74713-59-0 | PKC | ||
A cell-permeable ceramide analog | |||||
| GC60317 | RA-9 | 919091-63-7 | Deubiquitinase | ||
RA-9 is a cell-permeable, potent and selective inhibitor of proteasome-associated deubiquitinating enzymes (DUBs) with favorable toxicity profile and anticancer activity. RA-9 selectively induces apoptosis in ovarian cancer cell lines. | |||||
| GC60288 | Picrocrocin | 138-55-6 | Apoptosis | ||
Picrocrocin, the chemical most responsible for the bitter taste of saffron, is isolated from saffron and inhibits proliferation of cancer cells. | |||||
| GC62443 | ErSO | 2407860-35-7 | Apoptosis | ||
ErSO activates the anticipatory unfolded protein response (a-UPR) with an IC50 of 20.3 nM in MCF-7 cells. ErSO induces rapid and selective necrosis of ERα-positive breast cancer cell lines in vitro. | |||||
| GC65290 | Sintilimab | 2072873-06-2 | PD-1/PD-L1 interaction | ||
Sintilimab (anti-PD-1, IBI 308) is a fully human IgG4 monoclonal antibody that binds to PD-1 on the surface of T-cells, blocks the PD-1/PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells. | |||||
| GC34218 | Nivolumab (BMS-936558) | 946414-94-4 | PD-1/PD-L1 interaction | ||
Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。 | |||||
| GC16362 | AD57 (hydrochloride) | 2320261-72-9 | c-RET | ||
A polypharmacological cancer therapeutic | |||||
| GC14847 | Psoralidin | 18642-23-4 | Reactive Oxygen Species | ||
A furanocoumarin with anti-cancer activity | |||||
| GC38086 | Linderalactone | 728-61-0 | Other Apoptosis | ||
Linderalactone inhibits human lung cancer growth by modulating the expression of apoptosis-related proteins (Bax and Bcl-2) with an IC50 of 15 ?M in A-549 cells. Linderalactone induces G2/M cell cycle arrest and could also suppress the JAK/STAT signalling pathway. Linderalactone can be isolated from Radix linderae. | |||||
